2-Benzoylpyridine and copper(II) ion in basic medium: Hydroxide nucleophilic addition stabilized by metal complexation, reactivity, crystal structure, DNA binding study and magnetic behavior

Synthesis and structural, magnetic and spectroscopic characterization of iron(III) complexes with in situ formed ligands from methyl-2-pyridyl ketone transformations

Reactions of methyl-2-pyridyl ketone, pyCOMe, with FeCl₃·6H₂O in various solvents gave complexes [Fe₄Cl₆(OMe)₂(L1)₂]·0.7MeCN·0.4MeOH (1·0.7MeCN·0.4MeOH) and [Fe₃Cl₄(bicine)(L2)]·Me₂CO·0.2H₂O (2·Me₂CO·0.2H₂O). The ligands (L1)^2- = pyCO(Me)CHCOpy (in 1) and (L2)^2- = pyCO(Me)CH₂CO(OMe)py (in 2) are formed in situ, through an aldol reaction-type mechanism between the carbanion pyC(O)CH₂^- (formed by the nucleophilic attack of the MeO^- in pyCOMe) and pyCOMe which results in the formation of a new C-C bond. The intermediate compound undergoes attack in the -CH₂- or -CO- group by a MeO^- group, and the new ligands (L1)^2- and (L2)^2-, respectively, are formed. The molecular structure of 1 consists of three corner-sharing [Fe₂O₂] rhombic units in cis-arrangement. The two terminal Fe^III ions display distorted square pyramidal geometry and the two central Fe^III ions are distorted octahedral. The molecular structure of 2 consists of two corner-sharing [Fe₂O₂] rhombic units, with the two terminal Fe^III ions in distorted square pyramidal geometry and the central Fe^III in distorted octahedral. The differentiation in the coordination environment of the Fe^III ions in 1-2 is reflected in the values of the Mössbauer hyperfine parameters. In agreement with theoretical calculations, the square pyramidal sites exhibit a smaller isomer shift value in comparison to the octahedral sites. Magnetic studies indicate antiferromagnetic interactions leading to an S = 0 ground state in 1 and to an S = 5/2 ground state in 2, consistent with Electron Paramagnetic Resonance spectroscopy. Mössbauer spectra of 2 indicate the onset of relaxation effects below 80 K. At 1.5 K the spectrum of 2 consists of magnetic sextets. The determined hyperfine magnetic fields are consistent with the exchange coupling scheme imposed by the crystal structure of 2. Theoretical calculations shed light on the differences in the electronic structure between the square pyramidal and the octahedral sites.

Indium(III)/2-benzoylpyridine chemistry: interesting indium(III) bromide-assisted transformations of the ligand

Reactions of 2-benzoylpyridine, (py)(ph)CO, with InX₃ (X = Cl, Br) in EtOH at room temperature have been studied. The InCl₃/(py)(ph)CO system has provided access to complex [InCl₃{(py)(ph)CO}(EtOH)]·{(py)(ph)CO} (1) and the byproduct {(pyH)(ph)CO}Cl (2). The reaction of InBr₃ with (py)(ph)CO has led to a mixture of (L)[InBr₄{(py)(ph)CO}] (3) and [In₂Br₄{(py)(ph)CH(O)}₂(EtOH)₂] (4), where L⁺ is the 9-oxo-indolo[1,2-a]pyridinium cation and (py)(ph)CH(O)^- is the anion of (pyridin-2-yl)methanol. Based on solubility and crystallisation time differences between the two components of the mixture, complex 4 was isolated in pure form, i.e. free from 3. The formations of the counterion L⁺ and the coordinated (py)(ph)CH(O)^- anion represent clearly InBr₃-promoted/assisted transformations. Reaction mechanisms have been proposed for the formation of 2, 3 and 4. Complex 4 could also be isolated by the reaction of InBr₃ and pre-formed (py)(ph)CH(OH) in EtOH. The solid-state structures of 1, 3 and 4 were determined by single-crystal X-ray crystallography, while the identity of the salt 2 was confirmed by microanalyses and a variety of spectroscopic techniques, including ESI-MS spectra. In the indium(III) complexes, the metal ions are 6-coordinate with a distorted octahedral geometry. The halogeno groups (Cl^-, Br^-) in the three complexes are terminal. The (py)(ph)CO molecule behaves as a N,O-bidentate (1.11) ligand in 1 and 3. A terminal EtOH ligand completes the coordination sphere of In^III in 1. The alkoxo oxygen atoms of the two 2.21 (py)(ph)CH(O)^- ligands doubly bridge the In^III centers in 4 creating a {InIII2(μ-OR)₂}⁴⁺ core; a nitrogen atom of one reduced organic ligand, two bromo ions and one terminal EtOH molecule complete the 6-coordination at each metal centre. Complexes 1, 3 and 4 were characterised by IR and Raman spectroscopies, and the data were discussed in terms of their known solid-state structures. Molar conductivity data and ¹H NMR spectra were used in an attempt to probe the behaviour of the complexes in DMSO. The to-date observed metal ion-assisted/promoted transformations of (py)(ph)CO are also discussed.

Unprecedented copper(ii) coordination induced nucleophilic cleavage of a quinoxaline heterocycle: structural and computational studies

This research work deals with the unprecedented copper(ii) induced nucleophilic cleavage of a quinoxaline heterocycle with spectroscopic, structural and computational studies.

Anticancer Activity of Platinum (II) Complex with 2-Benzoylpyridine by Induction of DNA Damage, S-Phase Arrest, and Apoptosis

OBJECTIVE

To overcome the disadvantages of cisplatin, numerous platinum (Pt) complexes have been prepared. However, the anticancer activity and mechanism of Pt(II) complexed with 2-benzoylpyridine [Pt(II)- Bpy]: [PtCl2(DMSO)L] (DMSO = dimethyl sulfoxide, L = 2-benzoylpyridine) in cancer cells remain unknown.

METHODS

Pt(II)-Bpy was synthesized and characterized by spectrum analysis. Its anticancer activity and underlying mechanisms were demonstrated at the cellular, molecular, and in vivo levels.

RESULTS

Pt(II)-Bpy inhibited tumor cell growth, especially HepG2 human liver cancer cells, with a halfmaximal inhibitory concentration of 9.8±0.5μM, but with low toxicity in HL-7702 normal liver cells. Pt(II)- Bpy induced DNA damage, which was demonstrated through a marked increase in the expression of cleavedpoly (ADP ribose) polymerase (PARP) and gamma-H2A histone family member X and a decrease in PARP expression. The interaction of Pt(II)-Bpy with DNA at the molecular level was most likely through an intercalation mechanism, which might be evidence of DNA damage. Pt(II)-Bpy initiated cell cycle arrest at the S phase in HepG2 cells. It also caused severe loss of the mitochondrial membrane potential; a decrease in the expression of caspase-9 and caspase-3; an increase in reactive oxygen species levels; the release of cytochrome c and apoptotic protease activation factor; and the activation of caspase-9 and caspase-3 in HepG2 cells, which in turn resulted in apoptosis. Meanwhile, changes in p53 and related proteins were observed including the upregulation of p53, the phosphorylation of p53, p21, B-cell lymphoma-2-associated X protein, and NOXA; and the downregulation of B-cell lymphoma 2. Moreover, Pt(II)-Bpy displayed marked inhibitory effects on tumor growth in the HepG2 nude mouse model.

CONCLUSION

Pt(II)-Bpy is a potential candidate for cancer chemotherapy.

Interesting copper(ii)-assisted transformations of 2-acetylpyridine and 2-benzoylpyridine

Novel Cu^II-assisted transformations have been observed in the reactions of copper(ii) sources and 2-pyridyl ketones.

A ratiometric fluorescent chemosensor for iron: discrimination of Fe2+ and Fe3+ and living cell application

A newly designed probe, 6-thiophen-2-yl-5,6-dihydrobenzo[4,5]imidazo-[1,2-c] quinazoline (HL(1)) behaves as a highly selective ratiometric fluorescent sensor for Fe(2+) at pH 4.0-5.0 and Fe(3+) at pH 6.5-8.0 in acetonitrile-HEPES buffer (1/4) (v/v) medium. A decrease in fluorescence at 412 nm and increase in fluorescence at 472 nm with an isoemissive point at 436 nm with the addition of Fe(2+) salt solution is due to the formation of mononuclear Fe(2+) complex [Fe(II)(HL)(ClO(4))(2)(CH(3)CN)(2)] (1) in acetonitrile-HEPES buffer (100 mM, 1/4, v/v) at pH 4.5 and a decrease in fluorescence at 412 nm and increase in fluorescence at 482 nm with an isoemissive point at 445 nm during titration by Fe(3+) salt due to the formation of binary Fe(3+) complex, [Fe(III)(L)(2)(ClO(4))(H(2)O)] (2) with co-solvent at biological pH 7.4 have been established. Binding constants (K(a)) in the solution state were calculated to be 3.88 × 10(5) M(-1) for Fe(2+) and 0.21 × 10(3) M(-1/2) for Fe(3+) and ratiometric detection limits for Fe(2+) and Fe(3+) were found to be 2.0 μM and 3.5 μM, respectively. The probe is a "naked eye" chemosensor for two states of iron. Theoretical calculations were studied to establish the configurations of probe-iron complexes. The sensor is efficient for detecting Fe(3+)in vitro by developing a good image of the biological organelles.